Sala Stampa

Dopo l’exit di Eos per 470M, Silvano Spinelli crea il primo acceleratore italiano di startup biotech

Sofinnova Partners, società di venture capital leader nel settore delle bioscienze, annuncia il lancio di BiovelocITA

di Redazione
Uncategorized @en

The top 7 Italian exits. When will Italy learn to “exit”?

Few, very few, startup acquisitions in 2013. Italians are often bought by foreigners, but is it really necessary to close the market at a national level?

di Ermanno Cece
Uncategorized @en

How to make a startup worth 400 mln. And now I want to help young people

An interview with Silvano Spinelli, the founder of EOS, which, thanks to a promising cancer treatment drug, was sold in the U.S. for a record sum. Project, money, corporate structure, vision: here is how he built the perfect startup. The next dream? Giving a hand in helping a new Italy emerge

di Riccardo Luna